Compare Platforms
Side-by-side comparison of synthetic biology platforms. Select up to 4.
| Spec | Ginkgo Bioworks | Twist Bioscience | Mammoth Biosciences |
|---|
| Company | Ginkgo Bioworks | Twist Bioscience | Mammoth Biosciences |
| Type | cell-programming | dna-synthesis | gene-editing |
| Chassis | Multiple (yeast, E. coli, mammalian) | N/A (DNA manufacturer) | Multiple |
| Vertical | tools | tools | therapeutics |
| Stage | COMMERCIAL | COMMERCIAL | CLINICAL |
| Funding | $2.8B+ | $900M+ | $600M+ |